10-Q
Quarterly Report
AMERICAN HEALTHCARE REIT, INC.
AHR
NYSE
CIK: 1632970
File #: 001-41951
Balance Sheet
51 line items · 2 periods
XBRL
| Item | Mar 31, 2026 | Dec 31, 2025 |
|---|---|---|
ASSETS | ||
Real estate investments, net | 4,319,911,000 | 4,183,419,000 |
International | 42,079,000 | 43,250,000 |
United States | 4,277,832,000 | 4,140,169,000 |
Debt security investment, net | 92,304,000 | 92,136,000 |
Cash and cash equivalents | 119,380,000 | 114,836,000 |
Restricted cash | 37,504,000 | 36,917,000 |
Accounts and other receivables, net | 241,594,000 | 204,313,000 |
Identified intangible assets, net | 250,424,000 | 253,236,000 |
Goodwill | 234,942,000 | 234,942,000 |
ISHC | 168,177,000 | 168,177,000 |
Triple-net leased properties | 18,953,000 | 18,953,000 |
OM | 47,812,000 | 47,812,000 |
Operating lease right-of-use assets, net | 130,405,000 | 135,399,000 |
Other assets, net | 172,194,000 | 171,028,000 |
Total assets | 5,598,658,000 | 5,426,226,000 |
ISHC | 2,718,571,000 | 2,686,143,000 |
SHOP | 1,426,363,000 | 1,273,714,000 |
Triple-net leased properties | 393,010,000 | 393,952,000 |
Other | 19,429,000 | 23,607,000 |
OM | 1,041,285,000 | 1,048,810,000 |
LIABILITIES, REDEEMABLE NONCONTROLLING INTEREST AND EQUITY | ||
Liabilities: | ||
Mortgage loans payable, net | 962,375,000 | 966,925,000 |
Lines of credit and term loan, net | 549,818,000 | 549,761,000 |
Revolving Loans - 2025 Trilogy Credit Facility | 0 | 0 |
Line of Credit - 2024 Credit Agreement | 550,000,000 | 550,000,000 |
Accounts payable and accrued liabilities | 340,265,000 | 317,742,000 |
Identified intangible liabilities, net | 1,978,000 | 2,110,000 |
Below-Market Lease | 1,978,000 | 2,110,000 |
Financing obligations | 33,675,000 | 33,902,000 |
Operating lease liabilities | 130,806,000 | 135,603,000 |
Security deposits, prepaid rent and other liabilities | 58,386,000 | 59,568,000 |
Total liabilities | 2,077,303,000 | 2,065,611,000 |
Equity: | ||
Stockholders’ equity: | ||
Preferred Stock | 0 | 0 |
Common Stock | 1,894,000 | 1,852,000 |
Additional paid-in capital | 5,065,446,000 | 4,880,169,000 |
Accumulated deficit | (1,583,441,000) | (1,559,279,000) |
Accumulated other comprehensive loss | (2,224,000) | (2,104,000) |
Total stockholders’ equity | 3,481,675,000 | 3,320,638,000 |
Noncontrolling interests | 39,680,000 | 39,977,000 |
Total equity | 3,521,355,000 | 3,360,615,000 |
Accumulated Deficit | (1,583,441,000) | (1,559,279,000) |
Accumulated Other Comprehensive Loss | (2,224,000) | (2,104,000) |
Additional Paid-In Capital | 5,065,446,000 | 4,880,169,000 |
Total Stockholders' Equity | 3,481,675,000 | 3,320,638,000 |
Common Stock | 1,894,000 | 1,852,000 |
Noncontrolling Interests | 39,680,000 | 39,977,000 |
Total liabilities and equity | 5,598,658,000 | 5,426,226,000 |